César A. Moran

60.1k citations

404 papers · 12.4k indexed · h-index 61

Neurology top 0.1%
Pulmonary and Respiratory Medicine top 0.2%
Surgery top 0.5%
Oncology top 0.5%
Epidemiology top 0.5%

Co-authors: Saul Suster Annikka Weissferdt Michael N. Koss Neda Kalhor Ignacio I. Wistuba Melissa L. Rosado-de-Christenson Carmen Behrens Nancy F. Fishback
Topics: Myasthenia Gravis and Thymoma (125 papers)Pituitary Gland Disorders and Treatments (48 papers)Medical Imaging and Pathology Studies (48 papers)
Cited by: Neurology Oncology Pulmonary and Respiratory Medicine
Journals: Nature Communications Journal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations: United States Japan China

In The Last Decade

César A. Moran

390 papers receiving 12.1k citations

Peers

Countries citing papers authored by César A. Moran

Since Specialization

Citations

This map shows the geographic impact of César A. Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by César A. Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites César A. Moran more than expected).

Fields of papers citing papers by César A. Moran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by César A. Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by César A. Moran. The network helps show where César A. Moran may publish in the future.

Co-authorship network of co-authors of César A. Moran

This figure shows the co-authorship network connecting the top 25 collaborators of César A. Moran. A scholar is included among the top collaborators of César A. Moran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with César A. Moran. César A. Moran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rosai-Dorfman Disease Mimicking Metastasis to the Spleen From Breast Cancer 2025 ·Clinical Nuclear Medicine ·(unknown),Lu Yang,Reza J. Mehran,César A. Moran,Carlos H. Bárcenas	0
2	Pulmonary Fungal Infections in a Tertiary Cancer Center: A Morphological Correlation of 160 Cases with CT and PET Imaging 2025 ·Diagnostics ·(unknown),Mylene T. Truong,César A. Moran	0
3	Effectiveness of interventions for informal caregivers of people with end-stage chronic illness: a systematic review 2024 ·Systematic Reviews ·(unknown),(unknown),Alana Christie,Claire Carswell,César A. Moran,Muhammad M. Yaqoob,S. J. Bolton,Robert Mullan,Soham Rej,Paul Gilbert,Clare McKeaveney,Clare McVeigh,Cheryl D. Tierney,Joanne Reid,Ian Walsh,T.L. Forbes,Helen Noble	2
4	Primary epithelioid hemangioendotheliomas and angiosarcomas of the pleura: a clinicopathological and immunohistochemical analysis of 13 cases 2023 ·Human Pathology ·Annikka Weissferdt,César A. Moran	1
5	Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer 2023 ·Nature Communications ·Edwin R. Parra,Jiexin Zhang,Mei Jiang,Auriole Tamegnon,Renganayaki Pandurengan,Carmen Behrens,Luisa M. Solis,Cara Haymaker,John V. Heymach,César A. Moran,J. Jack Lee,Don L. Gibbons,Ignacio I. Wistuba	22
6	Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer 2018 ·Clinical Cancer Research ·Yang Xie,Wei Lü,Shidan Wang,Ximing Tang,Hao Tang,Yunyun Zhou,César A. Moran,Carmen Behrens,Jack A. Roth,Qinghua Zhou,David H. Johnson,Stephen G. Swisher,John V. Heymach,Vassiliki A. Papadimitrakopoulou,Guanghua Xiao,John D. Minna,Ignacio I. Wistuba	13
7	Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients 2016 ·Clinical Cancer Research ·Edwin R. Parra,Carmen Behrens,Jaime Rodriguez‐Canales,Heather Lin,Barbara Mino,Jorge Blando,Jianjun Zhang,Don L. Gibbons,John V. Heymach,Boris Sepesi,Stephen G. Swisher,Annikka Weissferdt,Neda Kalhor,Julie Izzo,Humam Kadara,César A. Moran,J. Jack Lee,Ignacio I. Wistuba	103
8	Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations 2015 ·Cancer Research ·Erick Riquelme,Carmen Behrens,Heather Lin,George R. Simon,Vassiliki A. Papadimitrakopoulou,Julie Izzo,César A. Moran,Neda Kalhor,J. Jack Lee,John D. Minna,Ignacio I. Wistuba	85
9	EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma 2013 ·Clinical Cancer Research ·Carmen Behrens,Luisa M. Solis,Heather Lin,Ping Yuan,Ximing Tang,Humam Kadara,Erick Riquelme,Héctor Galindo,César A. Moran,Neda Kalhor,Stephen G. Swisher,George R. Simon,David J. Stewart,J. Jack Lee,Ignacio I. Wistuba	123
10	Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma 2013 ·Clinical Cancer Research ·Ignacio I. Wistuba,Carmen Behrens,Francesca Lombardi,Susanne Wagner,Junya Fujimoto,Maria Gabriela Raso,Lorenzo Spaggiari,Domenico Galetta,Robyn Riley,Elisha Hughes,Julia Reid,Zaina Sangale,S.G. Swisher,Neda Kalhor,César A. Moran,Alexander Gutin,Jerry S. Lanchbury,Massimo Barberis,Edward S. Kim	84
11	Intrathyroidal Parathyroid Carcinoma: Report of an Unusual Case and Review of the Literature 2013 ·SHILAP Revista de lepidopterología ·(unknown),William E. Winter,Mikhail Vaysberg,César A. Moran,Samer Z. Al‐Quran	23
12	Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis 2011 ·Clinical Cancer Research ·Ximing Tang,Humam Kadara,Carmen Behrens,Diane D. Liu,Yun Xiao,David C. Rice,Adi F. Gazdar,Junya Fujimoto,César A. Moran,Marileila Varella‐Garcia,J. Jack Lee,Waun Ki Hong,Ignacio I. Wistuba	59
13	Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients 2011 ·Clinical Cancer Research ·Yang Xie,Guanghua Xiao,Kevin R. Coombes,Carmen Behrens,Luisa M. Solis,Gabriela Raso,Luc Girard,Heidi S. Erickson,Jack A. Roth,John V. Heymach,César A. Moran,K. D. Danenberg,John D. Minna,Ignacio I. Wistuba	130
14	Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome 2011 ·Cancer ·Luisa M. Solis,Carmen Behrens,Maria Gabriela Raso,Heather Lin,Humam Kadara,Ping Yuan,Héctor Galindo,Ximing Tang,J. Jack Lee,Neda Kalhor,Ignacio I. Wistuba,César A. Moran	85
15	Pax8 Expression in Thymic Epithelial Neoplasms 2011 ·The American Journal of Surgical Pathology ·Annikka Weissferdt,César A. Moran	52
16	Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features 2010 ·Clinical Cancer Research ·Luisa M. Solis,Carmen Behrens,Wenli Dong,Milind Suraokar,Natalie Ozburn,César A. Moran,Alejandro H. Corvalán,Shyam Biswal,Stephen G. Swisher,B. Nebiyou Bekele,John D. Minna,David J. Stewart,Ignacio I. Wistuba	357
17	Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation 2009 ·Clinical Cancer Research ·Maria Gabriela Raso,Carmen Behrens,Matthew H. Herynk,Suyu Liu,Ludmila Prudkin,Natalie Ozburn,Denise M. Woods,Ximing Tang,Reza J. Mehran,César A. Moran,J. Jack Lee,Ignacio I. Wistuba	134
18	Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer 2008 ·Clinical Cancer Research ·Ludmila Prudkin,Carmen Behrens,Diane D. Liu,(unknown),Natalie Ozburn,B. Nebiyou Bekele,John D. Minna,César A. Moran,Jack A. Roth,Lin Ji,Ignacio I. Wistuba	68
19	Epidermal Growth Factor Receptor Abnormalities in the Pathogenesis and Progression of Lung Adenocarcinomas 2008 ·Cancer Prevention Research ·Ximing Tang,Marileila Varella‐Garcia,Ana C. Xavier,Erminia Massarelli,Natalie Ozburn,César A. Moran,Ignacio I. Wistuba	71
20	Neuroendocrine Carcinomas of the Thymus 2001 ·Pathology Case Reviews ·César A. Moran,Saul Suster	1

About César A. Moran

César A. Moran is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Oncology, having authored 404 papers that have together received 12.4k indexed citations. Recurring topics across this work include Myasthenia Gravis and Thymoma (125 papers), Pituitary Gland Disorders and Treatments (48 papers) and Medical Imaging and Pathology Studies (48 papers). The work is most often cited by research in Neurology (4.4k citations), Oncology (3.7k citations) and Pulmonary and Respiratory Medicine (4.3k citations). César A. Moran has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Saul Suster, Annikka Weissferdt, Michael N. Koss, Neda Kalhor, Ignacio I. Wistuba, Melissa L. Rosado-de-Christenson, Carmen Behrens, Nancy F. Fishback, Saul Suster and Stephen G. Swisher. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact